Vera Therapeutics Inc’s filing revealed that its Director SEIDENBERG BETH C unloaded Company’s shares for reported $0.72 million on Oct 28 ’24. In the deal valued at $48.03 per share,15,000 shares were sold. As a result of this transaction, SEIDENBERG BETH C now holds 131,553 shares worth roughly $6.4 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, BETH C SEIDENBERG bought 15,000 shares, generating $616,350 in total proceeds.
Before that, Fordyce Marshall sold 19,375 shares. Vera Therapeutics Inc shares valued at $782,610 were divested by the PRESIDENT AND CEO at a price of $40.39 per share. As a result of the transaction, Fordyce Marshall now holds 307,972 shares, worth roughly $14.99 million.
Scotiabank initiated its Vera Therapeutics Inc [VERA] rating to a Sector outperform in a research note published recently. A number of analysts have revised their coverage, including Oppenheimer’s analysts, who began to cover the stock in late January with a ‘”an Outperform”‘ rating. Cantor Fitzgerald began covering VERA with “an Overweight” recommendation on January 08, 2024. Raymond James started covering the stock on December 18, 2023. It rated VERA as “an Outperform”.
Price Performance Review of VERA
On Monday, Vera Therapeutics Inc [NASDAQ:VERA] saw its stock jump 1.21% to $48.67. Over the last five days, the stock has gained 7.75%. Vera Therapeutics Inc shares have risen nearly 216.45% since the year began. Nevertheless, the stocks have risen 322.85% over the past one year. While a 52-week high of $50.78 was reached on 03/01/24, a 52-week low of $10.79 was recorded on 01/19/24. SMA at 50 days reached $41.75, while 200 days put it at $40.26.
Levels Of Support And Resistance For VERA Stock
The 24-hour chart illustrates a support level at 47.93, which if violated will result in even more drops to 47.19. On the upside, there is a resistance level at 49.38. A further resistance level may holdings at 50.09. The Relative Strength Index (RSI) on the 14-day chart is 63.49, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 4.13, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 15.17%. Stochastics %K at 84.20% indicates the stock is a selling.
How much short interest is there in Vera Therapeutics Inc?
A steep rise in short interest was recorded in Vera Therapeutics Inc stocks on 2024-10-15, dropping by -0.27 million shares to a total of 6.19 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-13 was 6.46 million shares. There was a decline of -4.37%, which implies that there is a negative sentiment for the stock.
